Medical Journals

Signal Peptide Peptidase: Biochemical Properties and Modulation by Nonsteroidal Antiinflammatory Drugs.

Authors:
  • Sato Toru
  • Nyborg Andrew C
  • Iwata Nobuhisa
  • Diehl Thekla S
  • Saido Takaomi C
  • Golde Todd E
  • Wolfe Michael S

From: Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

Biochemistry

  • Publish Date: Jul 2006
  • ISSN: 0006-2960
  • Volume: 45
  • Issue: 28
  • Pages: 8649-56
  • Medium: Print
  • Language: English
  • Citation (JAMA): Sato Toru, Nyborg Andrew C, Iwata Nobuhisa, et al. Signal Peptide Peptidase: Biochemical Properties and Modulation by Nonsteroidal Antiinflammatory Drugs.. Biochemistry Jul 2006;45:8649-56

Abstract

Signal peptide peptidase (SPP) is an intramembrane aspartyl protease that cleaves remnant signal peptides after their release by signal peptidase. SPP contains active site motifs also found in presenilin, the catalytic component of the gamma-secretase complex of Alzheimer’s disease. However, SPP has a membrane topology opposite that of presenilin, cleaves transmembrane substrates of opposite directionality, and does not require complexation with other proteins. Here we show that, upon isolation of membranes and solubilization with detergent, the biochemical characteristics of SPP are remarkably similar to gamma-secretase. The majority of the SPP-catalyzed cleavages occurred at a single site in a synthetic substrate based on the prolactin (Prl) signal sequence. However, as seen with cleavage of substrates by gamma-secretase, additional cuts at other minor sites are also observed. Like gamma-secretase, SPP is inhibited by helical peptidomimetics and apparently contains a substrate-binding site that is distinct from the active site. Surprisingly, certain nonsteroidal antiinflammatory drugs known to shift the site of proteolysis by gamma-secretase also alter the cleavage site of Prl by SPP. Together, these findings suggest that SPP and presenilin share certain biochemical properties, including a conserved drug-binding site for allosteric modulation of substrate proteolysis.

Mesh Headings (Keywords): Amino Acid Sequence, Amyloid Precursor Protein Secretases, Animals, Anti-Inflammatory Agents, Non-Steroidal, Aspartic Endopeptidases, Binding Sites, Cell Line, Cell-Free System, Conserved Sequence, Endopeptidases, Humans, Molecular Sequence Data, Prolactin


Check for Full Text / PubMed Unique Identifier (PMID): 16834339


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.